Mansfield, MA -- July 26, 2004 - Axeda Systems Inc. (Nasdaq: XEDA), the world's leading provider of device relationship management (DRM) software and services today announced, that the Olympus Diagnostic Systems Division, Life Science Group of Olympus Corporation, a precision technology leader in designing and delivering innovative solutions in healthcare and consumer electronics worldwide, (TYO: 7733), has licensed the Axeda DRM™ system for use on their AU® Series Chemistry-Immuno Analyzers.
The AU® series Chemistry-Immuno Analyzers were designed to provide greater efficiency for the high productivity demands of laboratories and hospitals. With Axeda DRM, instrument users will benefit from improved device uptime and performance, while Olympus will benefit from real-time access to critical instrument status and reportable information, enabling it to provide better customer service, faster and at lower costs.
"Device availability has always been crucial in the medical instrument industry, and Axeda DRM is rapidly gaining recognition as the most efficient, cost-effective method of remotely managing devices and reducing downtime," said Robert M. Russell Jr., chairman and chief executive officer of Axeda Systems. "The fact that increasing numbers of leading global medical instrument manufacturers like Olympus are choosing Axeda DRM is evidence that it is the solution of choice for the remote monitoring, management, and service of critical medical instruments worldwide."
The Axeda DRM system is a distributed software system that securely transmits status and usage data via the Internet from remote equipment to service representatives, alerting them if a device is operating outside preset performance standards. Axeda DRM leverages its patented Firewall-Friendly™ communications technology and existing network security within medical facilities. These and other features enable medical instrument companies to comply with regulations protecting patient information including 21 CFR Part 11 and HIPAA.
Olympus America Inc. will introduce its DRM branded solution to the U.S. market, at the AACC Annual Meeting in Los Angeles, CA July 25-29, 2004. Booth 701.
Axeda Systems Inc. (NASDAQ: XEDA) is the world's leading provider of device relationship management (DRM) software and services. Our flagship product, the Axeda DRM System™ helps manufacturing and service organizations increase revenue while lowering costs by proactively monitoring and managing devices deployed at customer sites around the world. Axeda DRM® leverages patented Firewall-Friendly™ technology that utilizes the public Internet to enable Machine-to-Machine (M2M) communication. It is the most scalable, field-proven, and comprehensive remote management solution available on the market today. Axeda customers include Global 2000 companies in multiple markets including Medical Instrumentation, Enterprise Technology, Industrial and Building Automation, Office Automation, and Semiconductor Equipment industries. Axeda has sales and service offices in the U.S., Europe, and Japan, and distribution partners worldwide. More information about Axeda is available at www.axeda.com.
Olympus Corporation, with its wholly owned subsidiaries, is a global leader in designing, manufacturing and sales of equipment and devices for medical and healthcare, imaging and information and industrial applications. The company leverages R&D investment in technology and manufacturing processes across diverse business lines that include: digital cameras, film cameras, IC recorders, binoculars, medical endoscopes, endotherapy instruments, ultrasound endoscopes and accessories, biological microscopes, clinical analyzers, genome analysis system, information processing equipment, industrial videoscopes, industrial microscopes.
Press Contact:
Erin Nolan Smith
Corporate
+1 508-718-6351
enolan@axeda.com
